Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary Investor Brand Network - Mon Dec 16, 11:51AM CST

Scinai Immunotherapeutics (NASDAQ: SCNI) has established a U.S.-based subsidiary, Scinai Bioservices Inc., to enhance its Contract Development and Manufacturing Organization (CDMO) operations and address...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Announces Strategic Board Appointment Investor Brand Network - Fri Dec 6, 11:30AM CST

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in the development of inflammation and immunology (“I&I”) biological products and offering CDMO services through its...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Welcomes Dr. Jonathan Sadeh to Scientific Advisory Board Investor Brand Network - Mon Dec 2, 8:22AM CST

Scinai Immunotherapeutics (NASDAQ: SCNI) has appointed Dr. Jonathan Sadeh to its Scientific Advisory Board, where he will support the advancement of the company’s IL-17 program and VHH antibody pipeline....

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Nine-Month Financial Results Investor Brand Network - Mon Nov 25, 10:33AM CST

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) to Spotlight I&I Pipeline, CDMO Services at BIO-Europe 2024 Investor Brand Network - Thu Oct 31, 9:00AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI) will showcase its inflammation and immunology (“I&I”) product pipeline and contract development and manufacturing (“CDMO”) services at the BIO-Europe 2024...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Schedules Virtual Panel Discussion Investor Brand Network - Tue Sep 17, 11:51AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) CEO Featured on Latest Episode of BioMedWire Podcast Investor Brand Network - Tue Sep 10, 8:15AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI), EIB Close on Loan Restructuring Agreement Investor Brand Network - Thu Aug 22, 8:59AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Enters Into $2M Investment Commitment Agreement Investor Brand Network - Wed Aug 21, 8:03AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices...

SCNI : 3.40 (+0.89%)
Scinai Immunotherapeutics (NASDAQ: SCNI) Reports Q2 2024 Financial Results Investor Brand Network - Fri Aug 16, 10:23AM CDT

Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai...

SCNI : 3.40 (+0.89%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot